UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| 1 |
Apple
AAPL
|
+$1.19B |
| 2 |
Elevance Health
ELV
|
+$275M |
| 3 |
Pinduoduo
PDD
|
+$160M |
| 4 |
Visa
V
|
+$159M |
| 5 |
Kanzhun
BZ
|
+$148M |
Top Sells
| 1 |
Automatic Data Processing
ADP
|
+$469M |
| 2 |
Amazon
AMZN
|
+$297M |
| 3 |
Baidu
BIDU
|
+$247M |
| 4 |
Microsoft
MSFT
|
+$239M |
| 5 |
TC Energy
TRP
|
+$214M |
Sector Composition
| 1 | Technology | 26.55% |
| 2 | Healthcare | 15.22% |
| 3 | Financials | 12.07% |
| 4 | Consumer Discretionary | 10.14% |
| 5 | Communication Services | 8.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1701
Amphastar Pharmaceuticals
AMPH
$1.3B
| $1.67M | ﹤0.01% |
47,885
+4,651
| +11% | +$162K |
|
1702
Employers Holdings
EIG
$983M
| $1.66M | ﹤0.01% |
39,731
+2,572
| +7% | +$108K |
|
|
B
1703
DELISTED
Barnes Group Inc.
B
| $1.66M | ﹤0.01% |
53,295
-1,786
| -3% | -$55.6K |
|
|
TWO
1704
Two Harbors Investment
TWO
$1.05B
| $1.65M | ﹤0.01% |
83,061
+4,584
| +6% | +$91.3K |
|
1705
Core & Main
CNM
$9.28B
| $1.65M | ﹤0.01% |
73,886
+7,977
| +12% | +$178K |
|
|
CERE
1706
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $1.64M | ﹤0.01% |
62,195
+28,373
| +84% | +$750K |
|
1707
Knowles
KN
$1.9B
| $1.64M | ﹤0.01% |
94,740
-486
| -0.5% | -$8.42K |
|
1708
Liberty Energy
LBRT
$1.73B
| $1.64M | ﹤0.01% |
128,542
+53,870
| +72% | +$687K |
|
|
MNTV
1709
DELISTED
Momentive Global Inc. Common Stock
MNTV
| $1.64M | ﹤0.01% |
186,182
+19,269
| +12% | +$170K |
|
|
GMS
1710
DELISTED
GMS Inc
GMS
| $1.63M | ﹤0.01% |
36,721
-32
| -0.1% | -$1.42K |
|
1711
Emergent Biosolutions
EBS
$434M
| $1.63M | ﹤0.01% |
52,589
-10,081
| -16% | -$313K |
|
1712
Warrior Met Coal
HCC
$3.04B
| $1.63M | ﹤0.01% |
53,227
-1,115
| -2% | -$34.1K |
|
1713
Direxion NASDAQ-100 Equal Weighted Index Shares
QQQE
$1.21B
| $1.63M | ﹤0.01% |
+25,817
| New | +$1.63M |
|
1714
Materion
MTRN
$2.31B
| $1.62M | ﹤0.01% |
22,030
+392
| +2% | +$28.9K |
|
1715
ePlus
PLUS
$1.97B
| $1.62M | ﹤0.01% |
30,552
-1,197
| -4% | -$63.6K |
|
1716
DNOW Inc
DNOW
$1.6B
| $1.62M | ﹤0.01% |
165,607
+21,371
| +15% | +$209K |
|
1717
Viper Energy
VNOM
$6.51B
| $1.61M | ﹤0.01% |
60,456
+10,500
| +21% | +$280K |
|
1718
Kratos Defense & Security Solutions
KTOS
$11.7B
| $1.61M | ﹤0.01% |
116,023
-1,793
| -2% | -$24.9K |
|
1719
Astrana Health
ASTH
$1.4B
| $1.61M | ﹤0.01% |
41,627
+3,550
| +9% | +$137K |
|
1720
Travere Therapeutics
TVTX
$2.09B
| $1.6M | ﹤0.01% |
66,165
-1,016
| -2% | -$24.6K |
|
1721
Liberty Latin America Class C
LILAK
$1.53B
| $1.59M | ﹤0.01% |
204,300
-81
| -0% | -$631 |
|
1722
XP
XP
$9.94B
| $1.59M | ﹤0.01% |
88,531
+11,324
| +15% | +$203K |
|
|
NTUS
1723
DELISTED
Natus Medical Inc
NTUS
| $1.59M | ﹤0.01% |
48,416
-273
| -0.6% | -$8.95K |
|
1724
Palomar
PLMR
$3.13B
| $1.58M | ﹤0.01% |
24,582
-483
| -2% | -$31.1K |
|
1725
Stewart Information Services
STC
$2.09B
| $1.58M | ﹤0.01% |
31,809
+1,571
| +5% | +$78.2K |
|